SAR408701

· Sanofi

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SAR408701, covering 2024-11-01 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors [Phase 1]